GlassScriptPhysician profile
Dustin Creech
NPI 1578884540
$745.78
in general payments reported to CMS, 2019-2025
19 companies · $69.78 in 2025
The $69.78 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $61.52 · 2022: $135 · 2023: $200 · 2024: $159 · 2025: $69.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $138.53 | 2019-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Novo Nordisk INC | $116.71 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $82.69 | 2022-2023 | Ubrelvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.16 | 2020-2024 | Xifaxan, Trulance |
| Bayer Healthcare Pharmaceuticals INC. | $56.93 | 2022-2024 | |
| Pfizer INC. | $48.77 | 2022-2025 | |
| Amgen INC. | $47.33 | 2019-2020 | |
| Insulet Corporation | $24.02 | 2024 | Omnipod |
| Lilly USA, LLC | $20.28 | 2025 | Jardiance |
| Medtronic, INC. | $19.27 | 2024 | Gi Genius |
| Merck Sharp & Dohme LLC | $19.25 | 2025 | Gardasil 9, Rotateq, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $17.40 | 2024 | Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.58 | 2024 | |
| Sanofi Pasteur INC. | $13.81 | 2023 | |
| Hologic Sales and Service, LLC | $13.78 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $13.50 | 2022 | |
| Allergan, INC. | $12.55 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.55 | 2020 | |
| Sumitomo Pharma America, INC. | $10.67 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dustin Creech listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.